News Category
Creative Biolabs is promoting its tumor organoid and immune cell co-culture services, including CAR-T models, to provide more physiologically relevant...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers address the key barriers limiting C...
GeoVax's $1 million revolving loan from Bowery Consulting Group comes with a major governance shake-up, as five directors resign and three lender nomi...
Bronwyn Brophy O'Connor will become CEO of Carl Zeiss Meditec AG on December 1, 2026, bringing extensive medtech leadership experience to drive the co...
Viromed Medical AG has completed a EUR 2 million capital increase, issuing 450,000 new shares at EUR 4.50 each, with proceeds earmarked for working ca...
PolyPeptide shareholders approved a new board and the removal of transfer restrictions, clearing key conditions for Samsung Biologics' tender offer.
RC Medical's physician-first venture studio model, highlighted by CEO David Ferrera, builds new companies around clinical problems observed in the int...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to execute a Phase 2 trial of Lucid...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to cut animal use and speed up development of its antibody-based cancer therapie...
SS Innovations International is advancing telerobotic surgery with its SSi Mantra system, reporting 195 telesurgeries and a 45% increase in installed ...
Lantern Pharma receives Taiwan regulatory and IRB approvals to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially accelerating developme...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to implement a Phase 2 trial of Luc...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could significantly reduce animal testing and accelerate the development of its ne...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business moves its novel myelin-protective multiple sclerosis drug Lucid-MS into ...
XORTX Therapeutics is advancing XORLO, a proprietary oxypurinol formulation, toward an FDA new drug application, aiming to address the growing need fo...
C60 Power's National C60 Day on October 9 highlights the 1996 Nobel Prize in Chemistry for fullerenes and the growing consumer interest in Carbon 60 w...
C60 Power celebrates National C60 Day on October 9, marking the Nobel Prize anniversary of the discovery of fullerenes, with educational events and a ...
New research reveals lymph node-like structures in the skull's bone marrow that could mobilize immune responses against brain diseases, opening doors ...
Gold prices rose for a second straight session, buoyed by bargain buying, a weaker dollar, and falling Treasury yields, with softer U.S. economic data...
Flushie, a family-owned pre-toilet spray brand founded in 2016, has achieved national recognition following its appearance at the International Housew...
SS Innovations International is expanding its SSi Mantra surgical robotic platform beyond India, with strong revenue growth and system installations, ...
Redwood AI Corp. has been named a co-applicant in a Terry Fox Research Institute grant to develop the SynoGraph oncology AI platform, aiming to improv...
A blood-based method for identifying cancer-specific proteins could replace the need for surgical tumor biopsies, potentially accelerating the develop...
American Fusion's latest Texatron experiments produced hotter, denser, and stable plasmas, marking a significant step toward practical fusion energy.
Dr. Jennifer S. Lawton will receive the American Heart Association's 2026 Basic Research Prize for her pioneering translational research in myocardial...
In vitro ADME studies are critical for early drug candidate assessment, improving success rates and reducing costs in pharmaceutical development.
GeoVax's next-generation MVA-X vaccine demonstrated durable single-dose protection against lethal Clade I mpox and other orthopoxviruses in preclinica...
B2i Digital will host a virtual investor conference on September 24, 2026, featuring live presentations from five financial services companies, provid...
The Marygold Companies reported an 8% revenue increase for fiscal 2026 and a reduced net loss, yet fourth-quarter results were hit by significant writ...
Onco-Innovations is integrating manufacturing, preclinical and regulatory activities for its lead cancer candidate ONC010, aiming to advance it toward...
VERAXA Biotech's appointment of Raju Willener as CFO brings deep capital markets expertise to advance its BiTAC oncology pipeline, signaling a strateg...
Nano-X Imaging's integrated platform combining digital X-ray, AI, cloud software, and teleradiology aims to broaden access to preventive healthcare an...
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has engaged IBN to enhance its corporate communications strategy as its subsidiary MindWave Inn...
Regentis Biomaterials CEO Dr. Ehud Geller discussed the company's lead product GelrinC for knee cartilage repair, its U.S. pivotal trial and European ...
Silo Pharma's U.S. patent allowance for SPC-15 strengthens its intellectual property portfolio and supports the development of a novel intranasal trea...
Goldman Sachs has revised its forecast to predict another Federal Reserve rate hike as soon as October, a move that could impact major sectors and con...
A new study reveals that the risk of sepsis, meningitis, or pneumonia from air pollution depends on individual bacterial strains, highlighting the nee...
Nightfood Holdings is expanding its TechForce Robotics platform beyond hospitality into high-growth automation markets, including pharmaceutical and s...
Invest Hong Kong leads a delegation of Mainland Chinese companies to Canada to foster collaboration in sustainability and life sciences, aiming to hel...
Peptide Wholesale Supply has expanded its HPLC verification protocols to bulk orders of BPC-157, Semaglutide, and Tirzepatide, providing batch-specifi...
Incorporating clinical trial discussions into the initial appointment for small cell lung cancer can provide patients with timely access to emerging t...
Regentis Biomaterials is advancing GelrinC, a hydrogel implant designed to regenerate knee cartilage, with European approval and an FDA-authorized piv...
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to discuss expanding its natural ...
Med-X is advancing its Nature-Cide natural pest-control brand as it prepares for a Nasdaq listing, with recent OMRI certification opening opportunitie...
Telomir Pharmaceuticals' Telomir-Zn demonstrated growth inhibition in human and canine osteosarcoma cell lines, supporting further studies that could ...
Quantum BioPharma's FDA clearance of its IND for Lucid-MS allows the company to initiate a Phase 2 trial in multiple sclerosis, a critical step for a ...
GeoVax's agreement with CEPI to use its Centralised Laboratory Network for the Phase 3 trial of GEO-MVA aims to provide independent validation and div...
New research from the Framingham Heart Study suggests that aortic stiffening, not menopause, may be the primary driver of rising pulse pressure in wom...
